SCHEMBL31369739

SCHEMBL31369739

CS(=O)(=O)Nc1ccc(-c2ccc(C[C@H](N)C(=O)O)cc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 3/20 0.51
▸ KDM4E B2RXH2 2/20 0.50
▸ PTGS1 P23219 2/20 0.50
▸ ALDH1A1 P00352 1/20 0.50
▸ LMNA P02545 1/20 0.50
▸ HPGD P15428 1/20 0.50
▸ HTT P42858 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ ALPI P09923 1/20 0.50
▸ PKM P14618 1/20 0.50
▸ XIAP P98170 1/20 0.50
▸ KIF11 P52732 2/20 0.47
▸ TPH1 P17752 7/20 0.47
▸ GRB2 P62993 1/20 0.44
▸ RORA P35398 1/20 0.44
▸ RORC P51449 1/20 0.44
▸ NR1H2 P55055 1/20 0.44
▸ NR1H3 Q13133 1/20 0.44
▸ RORB Q92753 1/20 0.44
▸ CTSK P43235 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1595806 0.96 SLC7A5 (0.56) SLC7A5KDM4EPTGS1ALDH1A1LMNA
SCHEMBL1595807 0.96 SLC7A5 (0.56) SLC7A5KDM4EPTGS1ALDH1A1LMNA
SCHEMBL5607322 0.81 UQCRB (0.58) SLC7A5PTGS1ALDH1A1LMNAHPGD
SCHEMBL5607316 0.81 UQCRB (0.58) SLC7A5PTGS1ALDH1A1LMNAHPGD
SCHEMBL1596041 0.81 PTPRB (0.56) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL14338181 0.81 PTPRB (0.56) KDM4EALDH1A1LMNAHPGDHTT
SCHEMBL156189 0.81 SLC7A5 (0.74) SLC7A5KDM4EPTGS1ALDH1A1LMNA
SCHEMBL837014 0.81 SLC7A5 (0.74) SLC7A5KDM4EPTGS1ALDH1A1LMNA
SCHEMBL31689601 0.81 SLC7A5 (0.47) SLC7A5KDM4EPTGS1ALDH1A1LMNA
SCHEMBL31370060 0.81 SLC7A5 (0.56) SLC7A5KDM4EPTGS1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2024-12-05 — — US claimed
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES PEPTIDREAM INC (JP) 2024-12-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240400499-A1 NOVEL AMINO ACID DERIVATIVES BCAT1, BCAT2, PELP1 SLC7A5 66/4885KDM4E 3586/4885PTGS1 4090/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback